The stock has a market capitalization of $350.18 million, a price-to-earnings ratio of -9.70 and a beta of 2.59. TRVN Stock Summary. Privacy Notice, and Intraday data delayed at least 15 minutes or per exchange requirements. Get the latest Trevena Inc (TRVN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. What's going on at Trevena (NASDAQ:TRVN)? Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. TRVN: Get the latest Trevena stock price and detailed information including TRVN news, historical charts and realtime prices. The TRVN stock was last observed hovering at around $2.40 in the last trading session, with the day’s loss setting it -0.15% off its average median price target of $5.00 for the next 12 months. ... What You Should Know About Trevena's New Painkiller. Trevena Inc. (NASDAQ:TRVN) went up by 1.33% from its latest closing price compared to the recent 1-year high of $3.68. BRIEF-Trevena, HCW Amend Common Stock Sales Agreement To To Include Additional $50 Mln Of Shares Of Common Stock In ATM Offering Reuters – … Trevena Stock Forecast Cantor Fitzgerald just came out and issued a $5 price target in its recent Trevena stock forecast. Trevena started at outperform with $16 stock price target at FBR & Co. Trevena shares rally as FDA accepts painkiller marketing application for review, U.S. benchmarks absorb the November downdraft, S&P, Dow venture atop resistance ahead of the Fed, Trevena shares jump on study of 'tummy tuck' pain treatment, H.C. Wainwright Keeps a Buy Rating on Trevena (TRVN). Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Trevena against related stocks people have also bought. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. Previously, H.C. Wainwright analyst Douglas Tsao also raised his price target to $5 on the Olinvyk news. Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. TRVN Stock Summary With a price/sales ratio of 113.46, Trevena Inc has a higher such ratio than 96.37% of stocks in our set. Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. To see the top 5 stocks in the Biotechnology industry click here. SIGN UP. Trevena Inc. (NASDAQ: TRVN) is 154.49% higher on its value in year-to-date trading and has touched a low of $0.46 and a high of $3.68 in the current 52-week trading range. The stock has traded between $2.21 and $2.34 so far today. FDA Approves Trevena's Olinvyk Opioid For Use In … There are currently no items in this Watchlist. Volume today is 3,337,940 compared to average volume of 3,259,577. Trevena NASDAQ Updated Feb 24, 2021 12:00 AM. In addition to the average rating from Wall Street analysts, TRVN stock has a mean … A A. Trevena's Shares March Higher, Can It Continue? Since then, TRVN stock has increased by 219.3% and is now trading at $2.23. 5 Stock Gainers for Monday: Nikola, Silvercorp Metals, Trevena. A high-level overview of Trevena, Inc. (TRVN) stock. Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA. Trevena (NASDAQ: TRVN) shares traded higher on Monday after the company announced the initiation of its TRV027 study in COVID-19 patients in collaboration with Imperial College London. By using this site you agree to the Return on Equity for this stock declined to … Yahoo fait partie de Verizon Media. With a year-over-year growth in debt of -52.36%, Trevena Inc's debt growth rate surpasses only 5.9% of about US stocks. Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. 12:45p. Is the Options Market Predicting a Spike in Trevena (TRVN) Stock? View which stocks have been most impacted by COVID-19. News. OLINVYK is a new chemical entity approved by the FDA in August 2020. QQQ 331.02. The company Trevena, Inc. recorded it at $0. (RTTNews) - Shares of Trevena Inc. (TRVN) are gathering steam in the run-up to a regulatory catalyst, which is only just days away. The Average True Range (ATR) for Trevena Inc. is set at 0.14, with the Price to Sales ratio for TRVN stock … TRVN, Trevena Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Trevena Inc Stock Quote: TRVN Stock News, Quotes, Analysis | Investors.com Get real time news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Nov 05, 2020. An approval from the United States Food and Drug Administration almost always comes as a major boost for any pharmaceutical or biotech company. All quotes are in local exchange time. Log in to see them here or sign up to get started. Previously, H.C. Wainwright analyst Douglas Tsao also raised his price target to $5 on the Olinvyk news. Trevena stock spiked Monday morning after the Chesterbrook-based biopharmaceutical company received FDA approval for its new pain relief drug on its second try. Webull offers TRVN stock news, real time Trevena news help you invest smart. Trevena, Inc. is based in King of Prussia, Pennsylvania. Feb 21, 2017 9:06 AM EST. Has Trevena, Inc. Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. Trevena Stock Is a ‘Buy’ Ahead of Olinvyk Launch, Says Analyst Despite the recent pullback, Trevena (TRVN) stock has had an excellent 2020 with shares rocketing 182% year-to-date. Cookie Notice (). (TRVN) Outpaced Other Medical Stocks This Year? The Price to Book ratio for the last quarter was 4.23. Get the latest Trevena, Inc. TRVN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Trevena Stock Forecast. Company. The stock has traded between $2.21 and $2.34 so far today. Copyright © 2021 MarketWatch, Inc. All rights reserved. View today's stock price, news and analysis for Trevena Inc. (TRVN). More About Trevena Inc. Trevena Inc is an American biotechnology company. As of 2021 February 25, Thursday current price of TRVN stock is 2.140$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Trevena, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Intraday Data provided by FACTSET and subject to terms of use. Find the latest Trevena, Inc. (TRVN) stock quote, history, news and other vital information to help you with your stock trading and investing. Trevena Inc stock is higher by 147.13% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives TRVN stock a score of 67 out of a possible 100.. That rank is influenced by a fundamental score of 91.
56 Chevy Body For Sale, Fallout 4 Cbbe Harness, Hyena In Spanish, Best Cat Treats For Ferrets, Old Fashioned Iron, Dutchess County Obituaries 2019, Minority Mindset Course, My Phone Volume Is Low,